Scientific Opinion on the substantiation of health claims related to caffeine and increased fat oxidation leading to a reduction in body fat mass (ID 735, 1484), increased energy expenditure leading to a reduction in body weight (ID 1487), increased alertness (ID 736, 1101, 1187, 1485, 1491, 2063, 2103) and increased attention (ID 736, 1485, 1491, 2375) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to provide a scientific opinion on a list of health claims pursuant to Article 13 of Regulation (EC) No 1924/2006. This opinion addresses the scientific substantiation of health claims in relation to caffeine and increased fat oxidation leading to a reduction in body fat mass, increased energy expenditure leading to a reduction in body weight, increased alertness, and increased attention. The scientific substantiation is based on the information provided by the Member States in the consolidated list of Article 13 health claims and references that EFSA has received from Member States or directly from stakeholders.
The foods/food constituents that are the subjects of the health claims are Coffea arabica L. (coffee) and other Coffea spp., Paullinia cupana Kunth (guarana) and caffeine. The Panel considers that, whereas the foods/food constituents Coffea arabica L. and Paullinia cupana Kunth are not sufficiently characterised in relation to the claimed effects evaluated in this opinion, the food constituent caffeine is sufficiently characterised.